Objective-Obesity promotes a chronic inflammatory condition in adipose tissue (AT). Impairment of insulin sensitivity coincides with infiltration of T cells into AT in early stages of obesity, when macrophages are not yet present. Here, we examine the role of invariant natural killer T (iNKT) cells, a subtype of T cells activated by lipid antigens, on glucose and lipid metabolism in obesity. Approach and Results-Jα18 −/− mice, specifically lacking iNKT cells, and wild-type mice consumed a chow or high-fat diet for 10 weeks. One third of all T lymphocytes in the liver of wild-type mice were iNKT cells, whereas few were detected in AT. Diet-induced obesity increased blood glucose in both genotypes of mice, whereas glucose tolerance test revealed similar kinetics of glucose clearance in Jα18 −/− and wild-type mice. Under obese conditions, expression of inflammatory cytokines in AT did not differ between the groups, although the number of T cells and macrophages was lower in Jα18 −/− mice. Nonetheless, AT homeostasis in Jα18 −/− mice was altered evidenced by lower AT weight, smaller adipocytes, accelerated lipogenesis, increased expression of hormone-sensitive lipase, and accelerated basal lipolysis. Conclusions-iNKT cells do not affect glucose clearance but rather modulate lipid metabolism in both liver and AT. Only few iNKT cells are found in AT under lean and obese conditions, suggesting that their effects on lipid metabolism are mainly mediated in the liver, their primary host organ. (Arterioscler Thromb Vasc Biol. 2013;33:1189-1196.)
N atural killer T (NKT) cells are leukocytes that combine characteristics from both natural killer cells and T lymphocytes. In contrast to major histocompatibility complex class I and major histocompatibility complex II-restricted T cells, NKT cells recognize glycolipids presented by CD1d molecules. Two types of NKT cells can be distinguished based on their T cell receptors. Type I NKT cells express the invariant T cell receptor chain (Vα14-Vα18 [mouse], Vα24-Vα18 [human]), and they are restricted to recognize antigen presented by the major histocompatibility complex-related CD1d molecule. 1 They account for up to 30% of the liver lymphocytes in mice and are the focus of our study. 2 Type II NKT cells on the contrary may have several different Vα chains. 1 NKT cells were ascribed a crucial role in numerous pathologies and conditions, such as viral and bacterial infections, autoimmune diseases, atherosclerosis, and cancer; however, little is known about their role in adipose tissue (AT) inflammation and metabolic disorders. Obesity is associated with a chronic inflammatory condition in the AT, characterized by infiltration of macrophages and, as recently discovered, T cells. [3] [4] [5] Studies of diet-induced obesity (DIO) in mice have demonstrated impairment of insulin sensitivity coinciding with infiltration of T cells into AT in early stages of obesity, when macrophages were not yet present. 6 Although T cells might contribute to DIO-driven inflammation, they do not suffice to cause insulin resistance in hyperlipidemic, but lean, mice. 5 However, several proinflammatory cytokines produced by T cells impact on metabolic pathways in AT, including tumor necrosis factor-α, interleukin-6, and interferon-γ. 3, 5, 7 The liver has a central role in both glucose and lipid metabolism. Interestingly, it also harbors the main reservoir of NKT cells in the body, and these cells may exert a pronounced effect on lipid metabolism. In the current study, we examined
Results iNKT Cells Are a Major Lymphocyte Population in Liver, but Not in AT
Staining with α-GalCer-loaded CD1d-Ig dimer protein (DimerX) was used in combination with anti-NK1.1 to identify iNKT cells in AT and liver. Flow cytometric analysis of liver leukocytes confirmed specific deficiency of iNKT cells in Jα18 −/− mice (<0.2%), whereas this population represented 32% of all CD4 + T cells in the liver of wild-type mice ( Figure 1A and 1B) . In contrast to liver, AT of wild-type as well as Jα18 −/− mice contained very few or no iNKT cells, respectively ( Figure 1D and 1E). Jα18 −/− mice contained a slightly increased subpopulation of CD4 + lymphocytes that expressed NK1.1 but did not bind DimerX ( Figure IC and ID in the online-only Data Supplement), probably representing a CD1d-independent NKT cell or an NKT-cell like T cell population. Additional analyses using counting beads revealed that AT contained <1000 iNKT cells per gram tissue, whereas this number was ≈200-fold higher in the liver ( Figure 1C and 1F). Furthermore, real-time polymerase chain reaction analysis for the specific Vα14Jα18 T-cell receptor mRNA of liver and AT confirmed that iNKT cells are not present in Jα18 −/− mice ( Figure IA and IB in the online-only Data Supplement).
Absence of iNKT Cells Does Not Influence Glucose Clearance
To examine the impact of iNKT cell deficiency on glucose metabolism, intraperitoneal glucose tolerance test was performed on wild-type and Jα18 −/− mice that consumed high-fat diet (HFD) or chow diet for 10 weeks. Although fasting glucose did not differ between the groups (Figure 2A ), Jα18 −/− mice had lower body and fat weight, irrespective of the diet ( Figure 3A and 3B). Intraperitoneal glucose tolerance test revealed that lack of iNKT cells does not affect blood glucose clearance after consuming chow diet. DIO impaired blood glucose clearance similarly in Jα18 −/− and wild-type mice ( Figure 2B and 2C). Similar results were obtained when mice were fasted for only 6 hours before performing intraperitoneal glucose tolerance test ( Figure IIA and IIB in the onlineonly Data Supplement). In addition, fasting insulin levels in the circulation were lower in Jα18 −/− than in wild-type mice fed with a chow diet but did not differ significantly in mice fed with HFD ( Figure 2D ). We also measured the kinetics of insulin release after an IP glucose challenge. Interestingly, wild-type mice required much higher insulin levels to maintain glycemic control compared with Jα18 −/− mice ( Figure  2E ). Accordingly, calculation of the Homeostasis Model of Assessment-Insulin Resistance (HOMA-IR) confirmed that insulin sensitivity was better preserved in Jα18 −/− mice compared with controls ( Figure 2F ), which also was associated with enhanced expression of insulin-regulated glucose transporters (Glut2 and -4) in liver and AT, respectively ( Figure  2G ). Plasma leptin concentration was decreased in Jα18 −/− mice on HFD as compared with wild-type mice ( Figure 2H ), whereas circulating levels of adiponectin were unaltered in Jα18 −/− compared with wild-type mice ( Figure 2I ). 
iNKT Cell-Deficient Mice Have Less Fat, Smaller Adipocytes, but Similar Lean Body Mass
The diminished body weight and AT mass ( Figure 3A and 3B) resulted from both lower weight at study start and diminished weight gain over the period of HFD consumption ( Figure IIC and IID in the online-only Data Supplement). These data led us to investigate body composition in HFD-fed mice. Indeed, the reduced body fat weight in Jα18 −/− mice was confirmed by MRI and attributable to both smaller visceral and subcutaneous fat depots, whereas lean body mass was unchanged ( Figure  3C -3G). This decrease in body fat suggested differences in AT homeostasis in Jα18 −/− mice. Indeed, adipocyte volume, calculated from the cell diameter, was decreased in Jα18 −/− mice, whereas the number of adipocytes was stable ( Figure 3H and 3I). This change in adipocyte size was observed under both dietary conditions but paralleled the reduced AT weight and overall body weight in Jα18 −/− mice, which appeared as a result of reduced food intake ( Figure 3J ). Of note, most parameters (eg, body weight, AT weight, glucose control) were confirmed in female mice (Figure IVA-IVD).
Increased Lipogenesis in iNKT Cell-Deficient Mice Is Counterbalanced by Elevated Lipase Expression and Basal Lipolysis
Lipogenesis, determined by incorporation of radio-labeled glucose into lipids of the adipocytes, was increased in iNKT celldeficient mice compared with wild-type mice with and without insulin stimulation. Notably, in both strains of mice, lipogenesis was lower after consuming HFD when compared with those fed with chow diet ( Figure 4A and 4B). Increased lipogenesis in AT of Jα18 −/− mice did not result in elevated plasma triglyceride or cholesterol concentrations ( Figure 4C and 4D) on chow diet or HFD. Considering this discrepancy, we analyzed mRNA for lipoprotein lipase (LPL) and hormone-sensitive lipase (HSL), the 2 major enzymes involved in degradation and hydrolyzation of triglycerides in AT. Indeed, quantitative polymerase chain reaction revealed increased expression of LPL and HSL in Jα18 −/− mice consuming both types of diet, suggesting that the elevated lipogenesis was counterbalanced by enhanced triglyceride breakdown, leading to an overall accelerated triglyceride metabolism in AT of mice lacking iNKT cells ( Figure 4E ). In accordance with the key role of LPL and HSL in lipolysis, we observed significantly increased lipolysis in Jα18 −/− mice on HFD, whereas a similar tendency was seen in the mice on chow diet ( Figure 4F ). Additional hormonal stimulation of lipolysis did not differ between wild-type and Although iNKT cell deficiency influences lipid metabolism in AT, no change in expression of genes involved in triglyceride formation (Dgat) or cholesterol synthesis (HMG-CoA reductase) was observed in the liver (Figure 4G and 4H) . The latter observation is consistent with the unaltered cholesterol concentrations measured in the plasma ( Figure 4D ).
Moreover, mRNA expression of hepatic lipase and MTTP was unaffected in the liver of Jα18 −/− mice. As expected, LIGHT mRNA was decreased in Jα18 −/− mice in both dietary conditions ( Figure 4G and 4H) , probably because of the absence of LIGHT-expressing iNKT cells in the liver. Finally, levels of free fatty acids increased in mice of both genotypes but did not differ between wild-type mice and those deficient for iNKT cells, suggesting operation of additional mechanism of free fatty acids catabolism ( Figure 4I ).
Lack of iNKT Cells Does Not Influence Expression of Inflammatory Genes in AT of DIO Mice
Quantitative polymerase chain reaction analysis revealed a diminished inflammatory response in the liver of Jα18 −/− compared with wild-type mice after consuming either chow diet or HFD ( Figure VA -VC in the online-only Data Supplement; Figure 5E ). Absolute numbers of leukocytes and their major subsets, such as macrophages and T cells, were decreased in the liver of Jα18 −/− mice compared with wild-type controls, both when calculating total cells per organ ( Figure 5B Figure 5F -5I), no difference in expression of any of the immune-related transcripts was found in the AT, suggesting that these cells do not directly influence obesity-induced AT inflammation ( Figure 5J ; Figure VE in the online-only Data Supplement). Of note, total numbers of leukocytes and their subsets were considerably higher in liver than in AT ( Figure 5 ) mirroring the distribution of iNKT cells ( Figure 1C and 1F) , and suggesting that lack of these cells may influence processes in their primary host organ more potently than in AT.
Discussion
The results of the present study show that iNKT cells modulate lipid and insulin metabolism without directly affecting plasma glucose clearance. Furthermore, they show that metabolically active iNKT cells reside in much greater numbers in the liver rather than in AT. Using a well-defined combination of markers for iNKT cells, we found only few of them in AT, despite repeated analyses of T cell subpopulations. However, we cannot exclude that these cells, although small in number, may actively modulate adipocyte metabolism. Our data are contrasted by groups reporting large numbers of iNKT cells in AT [8] [9] [10] but corroborate other studies that failed to detect iNKT cells in AT. 11, 12 Although we cannot provide a final explanation for this controversy, differences in preparation or experimental protocols are most likely. For instance, subtle differences in the genetic background of the mouse strains under study, as well as microbiological conditions in the different animal facilities, could influence the metabolic and immune state of the animals. 13 Furthermore, analytical methods differ with regard to flow cytometric staining procedures and reagents (eg, we used aGalCer-loaded CD1d dimer, whereas others used CD1d tetramers), and the present study is the only one using mRNA analysis to validate conclusions from flow cytometric data. In addition, we found considerable binding of the CD1d dimer to dead cells, which were excluded from our quantitative analysis (data not shown). Finally, HFD may change the activation status of the iNKT cells and influence the expression level of their specific T cell receptors, thus compromising conclusions when using CD1d multimers.
The impairment of glucose clearance on HFD was similar in mice that lack iNKT cells as in wild-type mice. This is in line with a recent published article by Mantell et al 11 but contrasts the findings of Ohmura et al. 14 We observed that lack of iNKT cells results in better insulin sensitivity reflected by lower insulin levels and elevated basal expression of insulinsensitive glucose transporters in liver and AT. However, this increased sensitivity did not result in improved glucose clearance, probably as a result of lower insulin level secreted by the mice lacking iNKT cells. We further investigated the cross-talk between glucose and lipid metabolism using the mice devoid of iNKT cells attributable to targeted deletion of the iNKT cell-specific Jα18 T cell receptor gene. Our study revealed that iNKT cells mainly reside in the liver, and that their absence leads to the following: (1) diminished inflammatory response in liver; (2) increased lipogenesis, which is counterbalanced by increased HSL and LPL expression and increased lipolysis; and (3) decreased adipocyte volume.
Although a possible malignant role in glucose metabolism was recently proposed, 14 our data rather suggest that iNKT cells residing in the liver influence AT homeostasis. We observed that mice lacking iNKT cells have lower body weight, implying that AT homeostasis may differ compared with wild-type mice. Indeed, adipocytes from Jα18 −/− mice were smaller than those of control mice, whereas their number did not change. In addition, MRI analysis revealed similar lean body mass in the 2 groups, whereas Jα18 −/− mice displayed a reduction of total body fat that was attributable to both the visceral and subcutaneous fat compartment.
Several factors define AT homeostasis, the balance of triglyceride synthesis (lipogenesis), and breakdown of triglyceride (lipolysis) in adipocytes on one hand and uptake of triglycerides from the circulation on the other. The dynamics of adipose lipid turnover seem to play a major role in metabolic disease. 15 Indeed, although smaller in volume, adipocytes from Jα18 −/− mice have an increased turnover of triglycerides from the circulation indicated by increased expression of LPL in AT. Furthermore, we detected elevated expression of HSL in AT. Of note, LPL and HSL expression and activity can be regulated by different cytokines. Both tumor necrosis factor-α, which was decreased in AT and liver of Jα18 −/− mice fed with normal chow diet, and interferon-γ, which was decreased in the liver, are known to inhibit LPL and HSL. [16] [17] [18] HSL is the key enzyme initiating adipocyte lipolysis, 19, 20 and we could demonstrate that the increased HSL expression in Jα18 −/− mice is accompanied by increased (basal) lipolysis. The increased lipolysis potentially promotes release of free fatty acids that is counterbalanced by improved lipogenesis overall, resulting in plasma triglyceride concentrations that are similar to that of wild-type mice. The discrepancy between an increased lipolysis and unchanged free fatty acids levels in the Jα18 −/− mice may also be a consequence of enhanced catabolic processes that use circulating fatty acids and can also result from increased insulin sensitivity. 21 There is a strong connection between obesity and fatty liver disease, also termed nonalcoholic steatohepatitis, 22 indicating an indirect impact of cytokines/adipokines released in the liver or AT. Indeed, studies observed reduced NKT cell number in leptin-deficient ob/ob mice, 23 and adoptive transfer of NKT cells into ob/ob mice positively influenced glucose metabolism, resulting in decreased liver fat content. 24 Although the mechanisms underlying these findings are not fully understood, we studied the connection between liver and AT under obese conditions from another perspective by depleting iNKT cells, which resulted in decreased leptin secretion from AT. Indeed, iNKT cells may directly affect leptin release, but it is also possible that the morphological changes (ie, smaller adipocytes and lower fat mass) lead to reduced leptin secretion.
NKT cells are a diverse subpopulation of T cells, classification of which was refined over the past years. They have been described in AT as CD3 + NK1.1 + T cells. 4 Nowadays, it is widely accepted that the characterization of NKT cells only based on NK1.1 is not sufficient. 1 We used the combination of α-GalCer-loaded CD1d dimer (DimerX) and NK1.1 to identify iNKT cells and found only few iNKT cells in AT of wildtype mice. Of note, a minor DimerX -NK1.1 + T cell population could be detected in Jα18 −/− mice. These cells may represent type II NKT cells, the role of which in AT was recently studied by Satoh et al, 12 who corroborate our findings of minor presence and functional involvement of iNKT cells in AT inflammation during DIO. Another explanation is that these DimerX -NK1.1 + CD3 + CD4 + cells are mucosal-associated NKT cells, so far only detected in the liver, blood, spleen, lymph nodes, and bone marrow. 25 However, our study focused on the invariant CD1d-restricted iNKT cells, whereas other subsets were not further investigated.
Furthermore, we could not identify any changes in expression of inflammatory cytokines in AT of obese mice lacking iNKT cells compared with wild-type mice. Corroborating the pivotal role of iNKT cells in the liver, Jα18 −/− mice displayed a less inflammatory phenotype compared with the wild-type mice, evidenced by reduced CD3, interferon-γ, and LIGHT expression evoked by the removal of a major, liver-resident T lymphocyte population in these mice. Interestingly, LIGHT was previously shown expressed by hepatic iNKT cells and modulates liver metabolism. 26, 27 Although in our study, iNKT cell deficiency reduced cellular infiltrate in both liver and AT under obese conditions, transcripts of effector cytokines were lower only in the liver, suggesting that the reduced pathology is mainly mediated in this principal iNKT cell reservoir. Nonetheless, these changes in the liver may likely lead to a healthier AT phenotype and overall preserved insulin sensitivity. In turn, this enhanced insulin sensitivity in iNKT celldeficient mice may promote lipogenesis because this process is tightly regulated by insulin.
Our findings were sex-independent because we observed very similar results in female mice. However, male mice, which do not have pronounced hormonal fluctuations and develop more rapid obesity, are most widely used for studying DIO. 28 Hence, our study focused on the HFD response in male mice.
Notably, our conclusions differ from those recently presented by Ohmura et al, 14 who showed reduced numbers of inflammatory cells in AT and improved glucose control in β2 microglobulin-deficient (b2m −/− ) mice. The authors attribute these changes to the absence of NKT cells in these mice, 14 although β2 microglobulin also functions as a component of the major histocompatibility complex class I complex, 29 which is prerequisite for functional CD8 + T cells. Because of the absence of this major T cell population, a qualified assessment of the contribution of NK and all NKT cells to AT inflammation and metabolic disturbance by this study seems questionable. The important role of CD8 + T cells in AT inflammation and glucose intolerance was initially shown by Nishimura et al 30 and was recently confirmed by Mantell et al. 11 Using a mouse model that lacks CD1d, but otherwise has a complete T cell repertoire, they support our data that NKT cells do not impair glucose clearance. Here, we expand the current knowledge by using a highly specific mouse model lacking iNKT cells.
In summary, our data demonstrate a strong metabolic interaction between liver and AT. We show that depleting iNKT cells in the liver can influence AT homeostasis and lipid metabolism. 
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